Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Prenat Diagn ; 34(2): 163-7, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24218399

RESUMEN

OBJECTIVES: Cornelia de Lange syndrome (CdLS) is characterized by distinct facial features, growth retardation, upper limb reduction defects, hirsutism, and intellectual disability. NIPBL mutations have been identified in approximately 60% of patients with CdLS diagnosed postnatally. Prenatal ultrasound findings include upper limb reduction defects, intrauterine growth restriction, and micrognathia. CdLS has also been associated with decreased PAPP-A and increased nuchal translucency (NT). We reviewed NIPBL sequence analysis results for 12 prenatal samples in our laboratory to determine the frequency of mutations in our cohort. METHODS: This retrospective study analyzed data from all 12 prenatal cases with suspected CdLS, which were received by The University of Chicago Genetic Services Laboratories. Diagnostic NIPBL sequencing was performed for all samples. Clinical information was collected from referring physicians. RESULTS: NIPBL mutations were identified in 9 out of the 12 cases prenatally (75%). Amongst the NIPBL mutation-positive cases with clinical information available, the most common findings were upper limb malformations and micrognathia. Five patients had NT measurements in the first trimester, of which four were noted to be increased. CONCLUSION: We demonstrate that prenatally-detected phenotypes of CdLS, particularly severe micrognathia and bilateral upper limb defects, are associated with an increased frequency of NIPBL mutations.


Asunto(s)
Síndrome de Cornelia de Lange/genética , Micrognatismo/diagnóstico por imagen , Proteínas/genética , Deformidades Congénitas de las Extremidades Superiores/diagnóstico por imagen , Proteínas de Ciclo Celular , Estudios de Cohortes , Síndrome de Cornelia de Lange/complicaciones , Síndrome de Cornelia de Lange/diagnóstico por imagen , Femenino , Humanos , Recién Nacido , Micrognatismo/etiología , Mutación , Medida de Translucencia Nucal , Embarazo , Diagnóstico Prenatal , Estudios Retrospectivos , Análisis de Secuencia de ADN , Ultrasonografía Prenatal , Deformidades Congénitas de las Extremidades Superiores/etiología
2.
Clin Genet ; 85(4): 353-8, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23611254

RESUMEN

Primary Autosomal Recessive Microcephaly (MCPH) is characterized by congenital microcephaly usually without additional clinical findings. The most common gene implicated in MCPH is ASPM and a large percentage of mutations described have been homozygous and in consanguineous families primarily of East Asian and Middle Eastern origin. ASPM sequencing was performed on 400 patients between the years 2009 and 2012. Seventy of the patient samples were also analyzed for copy number changes in the ASPM gene. Forty protein truncating mutations, including 29 novel mutations, were identified in 39 patients with MCPH. Approximately one third of patients were compound heterozygotes, indicative of non-consanguinity in these patients. In addition, 46 non-synonymous variants were identified and interpreted as variants of uncertain significance. No deletion/duplication in ASPM was identified in the patients analyzed. A wide ethnic distribution was observed, including the first reported patients with ASPM-related MCPH of Hispanic descent. Clinical information was collected for 26 of the ASPM-positive patients and 41 of the ASPM-negative patients. As more individuals are identified with MCPH, we anticipate that we will continue to identify ASPM mutation-positive patients from all ethnic origins supporting the occurrence of this genetic condition beyond that of consanguineous families of certain ethnic populations.


Asunto(s)
Microcefalia/genética , Mutación , Proteínas del Tejido Nervioso/genética , Patología Molecular , Preescolar , Consanguinidad , Etnicidad/genética , Genes Recesivos , Heterocigoto , Homocigoto , Humanos , Microcefalia/etiología
3.
Ir Med J ; 103(3): 88-9, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20666076

RESUMEN

An important aspect of prenatal diagnosis is the avoidance of emergency caesarean delivery (CD) where the abnormality is considered lethal and the infant will not survive. A consecutive cohort of 211,163 women delivered of infants weighing 500 grams or more in three tertiary referral centers from 01/95 to 12/04, was analyzed for perinatal death attributed to congenital malformations. In the group that died in the neonatal period, the emergency CD rate was significantly lower where anomaly was detected versus undetected (17.5% versus 31%). Further, in contrast to undiagnosed anomalies, the indication for emergency CD was more often maternal in the diagnosed group (42% versus 19%, p=0.019). When a diagnosis of lethal congenital anomaly has been made in the prenatal period, the reduction in the emergency CD rate by almost half in this study supports a pivotal role for prenatal diagnosis in optimizing maternal care.


Asunto(s)
Anomalías Congénitas/diagnóstico , Parto Obstétrico/métodos , Diagnóstico Prenatal , Distribución de Chi-Cuadrado , Femenino , Monitoreo Fetal , Humanos , Mortalidad Infantil , Recién Nacido , Irlanda/epidemiología , Embarazo
4.
Md Med ; 1(2): 30-2, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10835226
5.
J Clin Endocrinol Metab ; 70(6): 1668-73, 1990 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-2347900

RESUMEN

Chromogranin-A (CgA), also termed secretory protein-I, is an acidic glycoprotein that is synthesized and secreted by cells of the diffuse endocrine and neuroendocrine system. Several previous studies had suggested that plasma levels of CgA were elevated in patients with primary hyperparathyroidism. In the present study we sought to examine expression of the CgA gene in human parathyroid tissue from patients with primary hyperparathyroidism. We characterized the mRNAs coding for CgA and beta-actin in parathyroid tissue fragments obtained from 12 patients with parathyroid adenomas, 11 patients with familial multiple endocrine neoplasia type I (FMEN I) with parathyroid hyperplasia, and 11 normal subjects. The mRNAs were detected and analyzed by dot and Northern blot hybridization using cDNA probes. CgA mRNA transcripts of 2.1 kilobases were detected in normal and pathological parathyroids. Similarly, beta-actin mRNA species of 2.1 kilobases was present in all tissues. The relative level of parathyroid tissue CgA mRNA, calculated as the CgA/beta-actin mRNA ratio, was 73 +/- 18 in parathyroid adenoma, 73 +/- 20 in FMEN I, and 100 +/- 9 in controls (mean +/- SE; expressed as a percentage of the control reference group value). There were no significant differences among the steady state levels of CgA mRNA levels in these three groups (F = 0.98; P = 0.39). These results demonstrate that expression of CgA mRNA is qualitatively and quantitatively normal in parathyroid tumors from patients with FMEN I and parathyroid adenoma.


Asunto(s)
Cromograninas/genética , Hiperparatiroidismo/genética , Proteínas del Tejido Nervioso/genética , Glándulas Paratiroides/metabolismo , ARN Mensajero/biosíntesis , Adenoma/metabolismo , Adulto , Northern Blotting , Calcio/sangre , Cromogranina A , Cromograninas/biosíntesis , Sondas de ADN , Femenino , Expresión Génica , Humanos , Hiperparatiroidismo/metabolismo , Hiperplasia/metabolismo , Masculino , Persona de Mediana Edad , Glándulas Paratiroides/patología , Hormona Paratiroidea/sangre , Neoplasias de las Paratiroides/metabolismo
6.
Am J Med ; 84(3 Pt 2): 611-6, 1988 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-3348269

RESUMEN

Gonadal, adrenal, and thyroid functions were evaluated in 70 men seropositive for human immunodeficiency virus (HIV) infection, clinically categorized as asymptomatic (n = 19), AIDS-related complex (ARC) (n = 9), or acquired immunodeficiency syndrome (AIDS) (n = 42). Twenty of 40 men (50 percent) with AIDS were hypogonadal. Mean serum testosterone concentrations in both ARC (292 +/- 70 ng/dl) and AIDS (401 +/- 30 ng/dl) men were significantly less than in asymptomatic (567 +/- 49 ng/dl) or normal men (608 +/- 121 ng/dl). Of these hypogonadal men, 18 of 24 (75 percent) had hypogonadotropic hypogonadism. Seven of eight hypogonadal men (88 percent) had a normal gonadotropin response to gonadotropin-releasing hormone administration. Hypogonadism correlated with lymphocyte depletion and weight loss. Adrenal cortisol reserve, evaluated by adrenocorticotropin stimulation, was normal in 36 of 39 patients (92 percent) with AIDS. Indices of thyroid function were normal with the exception of one ARC man with a low free thyroxine index. In conclusion, hypogonadism is common in men with HIV infection and may be the first or most sensitive endocrine abnormality.


Asunto(s)
Complejo Relacionado con el SIDA/complicaciones , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Insuficiencia Suprarrenal/etiología , Hipogonadismo/etiología , Enfermedades de la Tiroides/etiología , Adulto , Humanos , Masculino , Estudios Prospectivos , Testosterona/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA